中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:(Yingyi CHEN)

1.0.05% cyclosporine eye drops(Ⅱ)combined with sodium hyaluronate eye drops in the treatment of moderate to severe dry eye associated with diabetes mellitus

Cancan SHI ; Xinshu LIU ; Shuwen CHEN ; Yingyi ZHAO ; Xiaofan YU ; He WANG ; Mingxin LI

International Eye Science 2025;25(6):886-893

2.Clinical prediction model for diabetic retinopathy based on ultra-widefield swept-source optical coherence tomography angiography

Xinshu LIU ; Cancan SHI ; Qing YU ; Shuwen CHEN ; Yingyi ZHAO ; He WANG ; Mingxin LI

International Eye Science 2025;25(6):999-1004

3.Evaluation on the early alterations in retinal and choroidal microvascular and microstructural characteristics of systemic lupus erythematosus patients via ultra-widefield swept-source optical coherence tomography angiography

Yingyi ZHAO ; Xinshu LIU ; Cancan SHI ; Mingxin LI ; Jili CHEN ; He WANG

International Eye Science 2025;25(7):1140-1146

4.Application of AI software for chromosomal aberration analysis in occupational health surveillance and radiation biological dose estimation

Yingyi PENG ; Qiuying LIU ; Zhifang LIU ; Zongjun ZHANG ; Xiaoyan CHEN ; Kunjie HUANG ; Qiying NONG ; Na ZHAO

China Occupational Medicine 2025;52(2):171-175

5.Relationship between school bullying and non-suicidal self-injury behaviors in adolescents with depressive disorders: the pathways of self-esteem and alexithymia

Liping LIU ; Min ZHANG ; Yingyi CHEN ; Binglan XU ; Lei DU ; Zhaoyuan XU

Sichuan Mental Health 2025;38(4):327-332

6.Relationship between plasma SP-A expression level and disease stage in silicosis patients

Kengkeng CHEN ; Bizhu ZHANG ; Yingyi PENG ; Zhifang LIU ; Xiaoyan CHEN ; Jiachun JIN

Shanghai Journal of Preventive Medicine 2024;36(2):203-206

7.Changing distribution and resistance profiles of Klebsiella strains in hospitals across China:results from the CHINET Antimicrobial Resistance Surveillance Program,2015-2021

Chuyue ZHUO ; Yingyi GUO ; Chao ZHUO ; Yang YANG ; Fupin HU ; Demei ZHU ; Yingchun XU ; Xiaojiang ZHANG ; Fengbo ZHANG ; Ping JI ; Yi XIE ; Mei KANG ; Chuanqing WANG ; Pan FU ; Yuanhong XU ; Ying HUANG ; Ziyong SUN ; Zhongju CHEN ; Yuxing NI ; Jingyong SUN ; Yunzhuo CHU ; Sufei TIAN ; Zhidong HU ; Jin LI ; Yunsong YU ; Jie LIN ; Bin SHAN ; Yan DU ; Sufang GUO ; Lianhua WEI ; Fengmei ZOU ; Hong ZHANG ; Chun WANG ; Yunjian HU ; Xiaoman AI ; Dawen GUO ; Jinying ZHAO ; Hua YU ; Xiangning HUANG ; Wen'en LIU ; Yanming LI ; Yan JIN ; Chunhong SHAO ; Xuesong XU ; Chao YAN ; Shanmei WANG ; Yafei CHU ; Lixia ZHANG ; Juan MA ; Shuping ZHOU ; Yan ZHOU ; Lei ZHU ; Jinhua MENG ; Fang DONG ; Zhiyong LÜ ; Fangfang HU ; Han SHEN ; Wanqing ZHOU ; Wei JIA ; Gang LI ; Jinsong WU ; Yuemei LU ; Jihong LI ; Jinju DUAN ; Jianbang KANG ; Xiaobo MA ; Yanping ZHENG ; Ruyi GUO ; Yan ZHU ; Yunsheng CHEN ; Qing MENG ; Shifu WANG ; Xuefei HU ; Jilu SHEN ; Wenhui HUANG ; Ruizhong WANG ; Hua FANG ; Bixia YU ; Yong ZHAO ; Ping GONG ; Kaizhen WEN ; Yirong ZHANG ; Jiangshan LIU ; Longfeng LIAO ; Hongqin GU ; Lin JIANG ; Wen HE ; Shunhong XUE ; Jiao FENG ; Chunlei YUE

Chinese Journal of Infection and Chemotherapy 2024;24(4):418-426

8.Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in TripleNegative Breast Cancer

Jiachen ZOU ; Liulu ZHANG ; Yuanqi CHEN ; Yingyi LIN ; Minyi CHENG ; Xingxing ZHENG ; Xiaosheng ZHUANG ; Kun WANG

Journal of Breast Cancer 2024;27(1):27-36

9.Preliminary study on HUVEC permeability changes in FNAIT induced by CD36 antibody

Yingyi TANG ; Dawei CHEN ; Wenjie XIA ; Xiuzhang XU ; Xin YE ; Bo HE

Chinese Journal of Blood Transfusion 2023;36(9):766-770

10.Liver macrophages show an immunotolerance phenotype in nonalcoholic fatty liver combined with Porphyromonas gingivalis-lipopolysaccharide infection.

Lijia GUO ; Yitong LIU ; Yingyi CHEN ; Junji XU ; Yi LIU

West China Journal of Stomatology 2023;41(4):385-394

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO